Clinical trial

Expanded Access to Mifomelatide for Cachexia in Adults With Advanced PDAC

NCT07399015

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Study timeline

Registry last updated2026-02-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pancreatic Ductal Adenocarcinoma (mPDAC)unresolved

Unresectable Pancreatic Ductal Adenocarcinomaunresolved

Metastatic PDACunresolved

Interventions

mifomelatideDRUG

Sponsors & collaborators

Endevica Biolead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07399015 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.